Irvine, CA – Telesair, a company dedicated to advancing respiratory care through innovative technology, and Vyaire Medical Inc., a longtime leader in respiratory care solutions, today entered into an agreement whereby Telesair has acquired the 510(k) clearance to sell and distribute the Avea disposable expiratory filter and water trap (11790), providing for continued availability of this critical accessory and the uninterrupted support for the Avea ventilation system.
This agreement is vital for maintaining access to critical respiratory care devices used in intensive care units and other healthcare settings. The Avea ventilator plays a vital role in hospitals, supporting patients with severe respiratory conditions. Ensuring the continued availability of high-quality consumables is crucial for both patient safety and clinical efficiency.
"Telesair is very pleased to serve AVEA customers again through this agreement with Vyaire to acquire the filter and water trap consumables for the Avea ventilators, and sales will commence immediately," said Randy Thurman, Chairman of Telesair and Founder, Chairman, and CEO of VIASYS Healthcare, the company that originally developed the Avea ventilators. "Avea ventilators were originally developed and marketed by VIASYS Healthcare, where Dr. Don Lin, Telesair CEO, was a leader in R&D. There is a substantial installed base of Avea ventilators in the U.S. and globally. With a significant installed base of Avea ventilators in the U.S. and globally, this agreement not only enables Telesair to continue serving clinicians and patients but also reinforces our commitment to ensuring seamless access to critical respiratory care supplies."
"At Telesair, we are committed to delivering innovative respiratory solutions and ensuring access to essential medical products," added Dr. Don Lin, CEO of Telesair. "Our agreement with Vyaire Medical reflects our shared dedication to supporting healthcare providers and ensuring continuity in patient care."
Further emphasized by Dirk Rassloff, CCO of Telesair, "The acquisition of the 510(k) underscores our dedication to supporting both patients and healthcare providers by ensuring continued access to critical medical devices and accessories. Although Telesair is a small MedTech company with limited resources, this acquisition demonstrates our commitment to providing solutions for patients, regulatory agencies, and clinical professionals."
With a substantial installed base of Avea ventilators in the U.S. and globally, this agreement ensures that patients and clinical professionals continue to receive the critical supplies they need. Telesair will now be responsible for the distribution and ongoing support of this product, ensuring a seamless transition.
For further information, please contact Avea_filter@telesair.com.
About Telesair
Telesair is focused on improving lives through disruptive respiratory technology. The company develops and commercializes hospital-grade respiratory devices and platforms designed to enhance patient outcomes and improve the delivery of respiratory care.
About Vyaire Medical
Vyaire Medical was a global leader in respiratory care, providing innovative solutions that help clinicians improve patient outcomes. With a legacy of expertise in ventilation, oxygen therapy, and pulmonary function testing, Vyaire contributed significantly to advancing respiratory care worldwide.